000			01924 a2200505 4500
005			20250513220430.0
264		0	_c20000914
008			200009s 0 0 eng d
022			_a0008-5472
040			_aNLM _beng _cNLM
100	1		_aHansen-Algenstaedt, N
245	0	0	_aTumor oxygenation in hormone-dependent tumors during vascular endothelial growth factor receptor-2 blockade, hormone ablation, and chemotherapy. _h[electronic resource]
260			_bCancer research _cAug 2000
300			_a4556-60 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAndrogens _xphysiology
650	0	4	_aAngiogenesis Inhibitors _xpharmacology
650	0	4	_aAnimals
650	0	4	_aAntibodies, Monoclonal _ximmunology
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology
650	0	4	_aCyclophosphamide _xadministration & dosage
650	0	4	_aDoxorubicin _xadministration & dosage
650	0	4	_aLuminescent Measurements
650	0	4	_aMale
650	0	4	_aMammary Neoplasms, Experimental _xblood supply
650	0	4	_aMice
650	0	4	_aMice, SCID
650	0	4	_aMicroscopy, Fluorescence _xmethods
650	0	4	_aNeoplasm Transplantation
650	0	4	_aNeoplasms, Hormone-Dependent _xblood supply
650	0	4	_aOrchiectomy
650	0	4	_aOxygen _xblood
650	0	4	_aOxygen Consumption
650	0	4	_aPartial Pressure
650	0	4	_aReceptor Protein-Tyrosine Kinases _xantagonists & inhibitors
650	0	4	_aReceptors, Growth Factor _xantagonists & inhibitors
650	0	4	_aReceptors, Vascular Endothelial Growth Factor
700	1		_aStoll, B R
700	1		_aPadera, T P
700	1		_aDolmans, D E
700	1		_aHicklin, D J
700	1		_aFukumura, D
700	1		_aJain, R K
773	0		_tCancer research _gvol. 60 _gno. 16 _gp. 4556-60
999			_c10917249 _d10917249